Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR-1918 in Homozygous Familial Hypercholesterolemia
NCT06009393Phase 2Completed
- Sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd.
- Start
- Dec 2023
- Primary completion
- Jun 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of SHR-1918 in homozygous familial hypercholesterolemia (HoFH), sponsored by Beijing Suncadia Pharmaceuticals Co., Ltd.. Started Dec 2023; status: completed.
02
Drugs
SHR-1918
03
Conditions
homozygous familial hypercholesterolemia (HoFH)
Beyond the preview
Go deeper on NCT06009393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06009393.